TLR7 and B-cell chronic lymphocytic leukemia: Although previous studies investigated the effect of multiple TLRs on CLL cells, targeting the metabolic pathways employed by malignant and normal B cells using TLRs, particularly TLR7/8 agonist, represents a novel research point.